Free Trial

Senti Biosciences (SNTI) SEC Filings & 10K Form

Senti Biosciences logo
$2.26 +0.06 (+2.49%)
Closing price 07/3/2025 03:33 PM Eastern
Extended Trading
$2.26 0.00 (0.00%)
As of 07/3/2025 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Senti Biosciences SEC Filings

DateFilerForm TypeView
06/30/2025
3:02 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2025
6:53 PM
COOPERSTONE BRENDA (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:53 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:55 PM
Hsiung Feng (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:55 PM
Collins James J. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:51 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:02 PM
Mathers Edward T (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
6:05 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:41 PM
Nantahala Capital Management, LLC (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13G/A
05/15/2025
3:43 PM
Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13G/A
05/06/2025
3:42 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
3:48 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
4:25 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form ARS
04/28/2025
6:12 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
11:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form EFFECT
03/31/2025
11:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form EFFECT
03/24/2025
5:02 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
5:12 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/21/2025
5:06 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:21 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
5:35 PM
BAYER HEALTHCARE LLC (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D
03/17/2025
2:01 PM
Celadon Partners SPV 24 (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D/A
03/14/2025
10:52 AM
Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
3:32 PM
Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
8:30 PM
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
8:20 PM
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
7:31 PM
BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:17 PM
Hsiung Feng (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
COOPERSTONE BRENDA (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:20 PM
Collins James J. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:21 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:23 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:00 PM
New Enterprise Associates 15, L.P. (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13D/A
03/10/2025
6:01 PM
Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:02 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:18 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
4:19 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
3:31 PM
Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form SCHEDULE 13G
02/06/2025
7:23 PM
Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
6:53 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
02/06/2025
4:30 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
6:30 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form DEF 14A
01/15/2025
3:15 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form PRE 14A
12/19/2024
3:34 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
12/16/2024
3:09 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
6:38 PM
BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:15 PM
Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:16 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
3:17 PM
Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:18 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
3:19 PM
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:18 PM
Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:02 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
7:26 AM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:51 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
3:32 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:05 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:42 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:19 PM
Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
3:17 PM
Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:30 PM
Mathers Edward T (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SNTI) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners